McKesson Corporation vs Stitch Fix Inc — how do they compare? McKesson Corporation trades at $824.42 (market cap $97.35B), while Stitch Fix Inc trades at $3.83 (market cap $520.36M). The key difference: McKesson Corporation is far larger — about 187.1× Stitch Fix Inc's market cap, and McKesson Corporation pays a 0.39% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals.
| MCK | SFIX | |
|---|---|---|
Market Cap | $97.35B | $520.36M |
Sector | Health | Consumer Cyclical |
52-Week High | $995.69 | $5.83 |
52-Week Low | $659.01 | $3.06 |
Enterprise Value | $101.98B | $408.08M |
Dividend Yield | 0.39% | — |
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
Stitch Fix (SFIX) trades at $3.935, up 3.83% on the day, showing signs of a potential turnaround with recent earnings beats and a bullish technical signal. The company reported a narrowed net loss in 2025, with revenue stabilizing at $1.27 billion and a gross margin of 43.66%. Analyst consensus is a $4.75 price target, though the stock remains near historic lows, presenting a value opportunity amid improving client metrics and AI-driven personalization efforts.
The outlook for SFIX hinges on sustained execution of its turnaround strategy, with risks including consumer spending pressure and competitive threats. Upside potential exists if margin improvements and active client growth continue, but investors should weigh the company's history of net losses against recent positive momentum and analyst caution, with 63.64% holding a neutral stance.
Trailing returns across standard periods
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →